| Breast cancer brain metastases: differences in survival depending on biological subtype, RPA RTOG prognostic class and systemic treatment after whole-brain radiotherapy (WBRT) A Niwińska, M Murawska, K Pogoda Annals of Oncology 21 (5), 942-948, 2010 | 250 | 2010 |
| Analysis of pattern, time and risk factors influencing recurrence in triple-negative breast cancer patients K Pogoda, A Niwińska, M Murawska, T Pieńkowski Medical oncology 30, 1-8, 2013 | 194 | 2013 |
| Breast cancer subtypes and response to systemic treatment after whole‐brain radiotherapy in patients with brain metastases A Niwińska, M Murawska, K Pogoda Cancer 116 (18), 4238-4247, 2010 | 102 | 2010 |
| Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations M Lambertini, L Ameye, AS Hamy, A Zingarello, PD Poorvu, E Carrasco, ... Journal of Clinical Oncology 38 (26), 3012-3023, 2020 | 82 | 2020 |
| Effects of BRCA Germline Mutations on Triple-Negative Breast Cancer Prognosis K Pogoda, A Niwińska, E Sarnowska, D Nowakowska, ... Journal of oncology 2020, 2020 | 57 | 2020 |
| Reference values for the EORTC QLQ-C30 in early and metastatic breast cancer J Mierzynska, M Taye, M Pe, C Coens, F Martinelli, K Pogoda, G Velikova, ... European Journal of Cancer 125, 69-82, 2020 | 52 | 2020 |
| Factors influencing survival in patients with breast cancer and single or solitary brain metastasis A Niwińska, K Pogoda, M Murawska, P Niwiński European Journal of Surgical Oncology (EJSO) 37 (7), 635-642, 2011 | 45 | 2011 |
| Determinants of prolonged survival for breast cancer patient groups with leptomeningeal metastasis (LM) A Niwińska, K Pogoda, W Michalski, M Kunkiel, A Jagiełło-Gruszfeld Journal of neuro-oncology 138, 191-198, 2018 | 40 | 2018 |
| Triple-negative breast cancer with brain metastases: a comparison between basal-like and non-basal-like biological subtypes A Niwińska, W Olszewski, M Murawska, K Pogoda Journal of Neuro-oncology 105, 547-553, 2011 | 26 | 2011 |
| Minimally important differences for interpreting EORTC QLQ-C30 change scores over time: A synthesis across 21 clinical trials involving nine different cancer types JZ Musoro, C Coens, MAG Sprangers, Y Brandberg, M Groenvold, ... European Journal of Cancer 188, 171-182, 2023 | 18 | 2023 |
| Clinical behavior and outcomes of breast cancer in young women with germline BRCA pathogenic variants M Lambertini, M Ceppi, AS Hamy, O Caron, PD Poorvu, E Carrasco, ... NPJ breast cancer 7 (1), 16, 2021 | 16 | 2021 |
| Limitations of systemic oncological therapy in breast cancer patients with chronic kidney disease A Bednarek, J Mykała-Cieśla, K Pogoda, A Jagiełło-Gruszfeld, M Kunkiel, ... Journal of Oncology 2020, 2020 | 16 | 2020 |
| Pregnancy after breast cancer in young BRCA carriers: an international hospital-based cohort study M Lambertini, E Blondeaux, E Agostinetto, AS Hamy, HJ Kim, A Di Meglio, ... JAMA 331 (1), 49-59, 2024 | 12 | 2024 |
| Safety of assisted reproductive techniques in young women harboring germline pathogenic variants in BRCA1/2 with a pregnancy after prior history of breast cancer M Condorelli, M Bruzzone, M Ceppi, A Ferrari, A Grinshpun, AS Hamy, ... ESMO open 6 (6), 100300, 2021 | 11 | 2021 |
| How to become a breast cancer specialist in 2018: The point of view of the second cohort of the Certificate of Competence in Breast Cancer (CCB2) G Montagna, D Anderson, J Bochenek-Cibor, I Bozovic-Spasojevic, ... The Breast 43, 18-21, 2019 | 10 | 2019 |
| microRNA Expression Profile in Single Hormone Receptor-Positive Breast Cancers Is Mainly Dependent on HER2 Status—A Pilot Study M Kunc, M Popęda, A Szałkowska, M Niemira, M Bieńkowski, R Pęksa, ... Diagnostics 10 (9), 617, 2020 | 8 | 2020 |
| Higher platelet counts correlate to tumour progression and can be induced by intratumoural stroma in non-metastatic breast carcinomas N Bednarz-Knoll, M Popęda, T Kryczka, B Kozakiewicz, K Pogoda, ... British Journal of Cancer 126 (3), 464-471, 2022 | 6 | 2022 |
| Metronomic chemotherapy in breast cancer K Pogoda, M Krzakowski, A Jagiełło-Gruszfeld Oncology in Clinical Practice 13 (4), 161-168, 2017 | 6 | 2017 |
| The outcome of special histologic types of triple-negative breast cancer (TNBC). K Pogoda, A Niwinska, M Murawska, W Olszewski, Z Nowecki Journal of Clinical Oncology 32 (15_suppl), 1122-1122, 2014 | 6 | 2014 |
| High expression of progesterone receptor may be an adverse prognostic factor in oestrogen receptor-negative/progesterone receptor-positive breast cancer: results of … M Kunc, R Pęksa, G Cserni, E Iżycka-Świeszewska, A Łacko, B Radecka, ... Pathology 54 (3), 269-278, 2022 | 5 | 2022 |
